Note 10: Operating income The following table summarizes the operating income during the three and six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | 2025 | | 2024 | | 2025 | | 2024 | Research tax credit | 1,465 | | | 1,161 | | | 2,217 | | | 2,568 | | | | | | | | | | | | | | | | | | Total | 1,465 | | | 1,161 | | | 2,217 | | | 2,568 | |
The decrease in Research tax credit during the six months ended June 30, 2025 was primarily due to the fact that a greater proportion of clinical studies activities were carried out in North America and were therefore not eligible to the French Research tax credit in 2025 compared to 2024, whereas the increase in Research tax credit during the three months ended June 30, 2025 was primarily due to the fact that more eligible activities have been carried out in the period, in particular with the launch of COMFORT Toddlers clinical trial explaining the increase of the research tax credit on a 3 months basis compared to a decrease on a 6 months basis.
|